Treatment With Once-weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults With Overweight or Obesity and Type 2 Diabetes: STEP 2 Post Hoc Analysis

Autor:	David Lau, John E Deanfield, Melanie Davies, Timothy W Garvey, Ole K Jeppesen, Usman Khalid, Mikhail Kosiborod, Robert F Kushner, Peter N Laursen, Domenica M Rubino, Subodh Verma
Rok vydání:	2022
Předmět:	Endocrinology Endocrinology Diabetes and Metabolism Internal Medicine General Medicine
Zdroj:	Canadian Journal of Diabetes. 46:S27-S28
ISSN:	1499-2671
DOI:	10.1016/j.jcjd.2022.09.079
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::58e416d42d8a4c521d417bd173a45bab https://doi.org/10.1016/j.jcjd.2022.09.079 Zobrazit plný text záznamu Full Text from ScienceDirect